| Cindy J Mcdowell, RN | |
|
99 Washington Ave, Suffern, NY 10901 | |
| (845) 357-4500 | |
| (845) 357-5059 |
| Full Name | Cindy J Mcdowell |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 99 Washington Ave, Suffern, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043682768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 340199 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cindy J Mcdowell, RN 99 Washington Ave, Suffern, NY 10901 Ph: (845) 357-4500 | Cindy J Mcdowell, RN 99 Washington Ave, Suffern, NY 10901 Ph: (845) 357-4500 |
News Archive
Paris, France and Camberley, UK – 21 December 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the detection of a new variant of COVID-19 by the UK's COVID19 Genomics UK consortium, known as VUI-202012/01, the Company has carried out a detailed analysis of the mutations in this new variant and in all published COVID-19 strains to fully assess the reliability of its existing diagnostic tests.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a Category 3 human abuse liability (HAL) study of Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product candidate in late-stage clinical development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A new analysis by health policy researchers at the University of Massachusetts Amherst who studied the effectiveness of the 1983 Orphan Drug Act finds that current incentives "are not sufficiently stimulating orphan drug development" by pharmaceutical companies, and patients with rare diseases and conditions still have unmet needs. Further, barriers to ethical and timely access remain.
Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.
By using mice lacking a crucial gene that controls the process of chromatin remodeling of cytokines including those responsible for inflammation and comparing them to normal wild type mice with the gene, researchers at the George Washington University School of Medicine and Health Sciences have shown that the gene, Mta1, is essential for the parasite Schistosoma haematobium to establish a productive infection and survival in the host.
› Verified 9 days ago
Lavinia Locust, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Washington Ave, Suffern, NY 10901 Phone: 845-357-4500 Fax: 845-357-5039 | |
Rebecca Klein, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5 Samego Ct, Suffern, NY 10901 Phone: 845-641-0297 | |
Davinder Kaur, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Washington Ave, Suffern, NY 10901 Phone: 845-357-4500 | |
Meggon Keyaira Vickers, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Suffern Place, Suffern, NY 10901 Phone: 845-357-4500 | |
Daniela Brickhouse, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Washington Ave, Suffern, NY 10901 Phone: 845-357-4500 Fax: 845-357-5039 | |
Rebecca A. Mierop, RN BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Washington Ave, Suffern, NY 10901 Phone: 845-357-4500 | |
Danielle Teresa Kunak, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Suffern Place, Suffern, NY 10901 Phone: 845-357-4500 Fax: 845-357-5039 |